Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 10/20 | 0.52 |
| ▸ | KDM1B | Q8NB78 | 3/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.36 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.36 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413013 | 1.00 | KDM1A (0.52) | KDM1AKDM1BCYP11B2GRIN2DGRIN3B | |
| SCHEMBL5993533 | 0.81 | CYP11B2 (0.54) | KDM1ACYP11B2 | |
| SCHEMBL852834 | 0.79 | IDO1 (0.39) | KDM1A | |
| SCHEMBL29442080 | 0.79 | IDO1 (0.39) | KDM1A | |
| SCHEMBL29785782 | 0.79 | KDM1A (0.46) | KDM1AKDM1BCYP11B2GRIN2DGRIN3B | |
| SCHEMBL483392 | 0.77 | KDM1A (0.65) | KDM1AKDM1BCYP11B2GRIN2DGRIN3B | |
| SCHEMBL8421976 | 0.75 | KDM1A (0.41) | KDM1A | |
| SCHEMBL30177612 | 0.73 | KDM1A (0.40) | KDM1AGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL4402522 | 0.72 | CHRNB2 (0.46) | CHRNB2CHRNA4 | |
| SCHEMBL10068329 | 0.72 | KDM1A (0.33) | KDM1AKDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3342821-B1 | RESIN COMPOSITION AND RESIN MOLDED BODY | ZEON CORP (JP) | 2025-04-23 | — | — | EP | claimed |
| EP-4737513-A1 | RUBBER COMPOSITION FOR TIRE, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4737515-A1 | RUBBER COMPOSITION FOR TIRES, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4737516-A1 | RUBBER COMPOSITION FOR TIRES, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4737517-A1 | RUBBER COMPOSITION FOR TIRE, AND TIRE | BRIDGESTONE CORPORATION (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12612487-B2 | Cycloolefin copolymer and hydrogenated product thereof, and optical element | ZEON CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| US-12601971-B2 | Negative photosensitive resin composition | ZEON CORPORATION (JP) | 2026-04-14 | — | — | US | disclosed |
| US-12595359-B2 | Resin composition for forming optical component, molded product, and optical component | MITSUI CHEMICALS, INC. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4703402-A1 | POLYMERIZABLE COMPOSITION AND MOLDED ARTICLE | RIMTEC Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260045492-A1 | COMPOSITE PARTICLES AND METHOD OF PRODUCING SAME, ELECTRODE FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | ZEON CORPORATION (JP) | 2026-02-12 | — | — | US | disclosed |
| WO-2022070871-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION | 日本ゼオン株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2022070958-A1 | METHOD FOR PRODUCING CYCLOOLEFIN COPOLYMER | ポリプラスチックス株式会社 | 2022-04-07 | — | — | WO | disclosed |
| EP-3978566-A1 | CYCLIC OLEFIN RESIN COMPOSITION, MOLDED ARTICLE AND OPTICAL COMPONENT | Mitsui Chemicals, Inc. (JP) | 2022-04-06 | — | — | EP | disclosed |
| EP-3971237-A1 | RESIN COMPOSITION FOR OPTICAL COMPONENT, MOLDED ARTICLE, AND OPTICAL COMPONENT | Mitsui Chemicals, Inc. (JP) | 2022-03-23 | — | — | EP | disclosed |
| EP-3960414-A1 | METHOD FOR PRODUCING CYCLOOLEFIN RESIN-DECORATIVE MOLDED ARTICLE | RIMTEC Corporation (JP) | 2022-03-02 | — | — | EP | disclosed |
| CN-106715597-B | Resin composition, method for producing heat-resistant resin film, and display device | 东丽株式会社 | 2022-03-01 | — | — | CN | disclosed |
| WO-2022034888-A1 | RESIN COMPOSITION AND METHOD FOR PRODUCING SAME, MOLDING MATERIAL, PACKAGING CONTAINER, AND SEMICONDUCTOR CONTAINER | 日本ゼオン株式会社 | 2022-02-17 | — | — | WO | disclosed |
| EP-3950765-A1 | RING-OPENING POLYMER HYDRIDE, RESIN COMPOSITION, AND MOLDED ARTICLE | Zeon Corporation (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2022024549-A1 | METHOD FOR PRODUCING CYCLOOLEFIN COPOLYMER | ポリプラスチックス株式会社 | 2022-02-03 | — | — | WO | disclosed |
| US-20220034868-A1 | CARDIOTOXICITY ASSESSMENT METHOD | ZEON CORPORATION (JP) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595359-B2 | Resin composition for forming optical component, molded product, and optical component | ASIC1, NLRP1, ASIC3 | KDM1A 1317/4885KDM1B 3327/4885CYP11B2 4398/4885 |
| US-20260045492-A1 | COMPOSITE PARTICLES AND METHOD OF PRODUCING SAME, ELECTRODE FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE | CACNA2D1, CACNA2D2, CACNA2D4 | KDM1A 1730/4885KDM1B 1781/4885CYP11B2 1776/4885 |
| US-12612487-B2 | Cycloolefin copolymer and hydrogenated product thereof, and optical element | HSF1, MALT1, HSPA4L | KDM1A 4736/4885KDM1B 4798/4885CYP11B2 2430/4885 |
| US-12601971-B2 | Negative photosensitive resin composition | ARCN1, RAD51, RER1 | KDM1A 458/4885KDM1B 1039/4885CYP11B2 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.